Showing results (501-510 of 607) with videos related to

Sort By:
Pageof 61
Cancer|November 15, 2019
Surveillance imaging for patients with head and neck cancer treated with definitive radiotherapy: A partially observed Markov decision process modelSweet Ping Ng, Temitayo Ajayi, Andrew J Schaefer, et al.
Cancer|April 19, 2021
Outcomes of patients with oropharyngeal squamous cell carcinoma treated with induction chemotherapy followed by concurrent chemoradiation compared with those treated with concurrent chemoradiationTheresa W Guo, Faiez Saiyed, Christopher M K L Yao, et al.
Cancer|December 28, 2016
Radiation therapy dose is associated with improved survival for unresected anaplastic thyroid carcinoma: Outcomes from the National Cancer Data BaseTodd A Pezzi, Abdallah S R Mohamed, Tommy Sheu, et al.
Cancer|January 17, 2018
Outcomes of patients diagnosed with carcinoma metastatic to the neck from an unknown primary source and treated with intensity-modulated radiation therapyMona Kamal, Abdallah S R Mohamed, Clifton David Fuller, et al.
Seminars in Radiation Oncology|May 9, 2018
Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to ActivationSteven J Frank, Pierre Blanchard, J Jack Lee, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 14, 2020
Lymphopenia during radiotherapy in patients with oropharyngeal cancerSweet Ping Ng, Houda Bahig, Amit Jethanandani, et al.
International Journal of Radiation Oncology, Biology, Physics|February 18, 2004
A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancyAndy Trotti, Adam Garden, Padraig Warde, et al.
Head & Neck|December 23, 2016
Recurrent oral cavity cancer: Patterns of failure after salvage multimodality therapySean R Quinlan-Davidson, William H Morrison, Jeffrey N Myers, et al.
Head & Neck|November 3, 2021
Risk stratification after recurrence of human papillomavirus (HPV)-related and non-HPV-related oropharyngeal cancer: Secondary analysis of NRG Oncology RTOG 0129 and 0522Elaine O Bigelow, Jonathan Harris, Carole Fakhry, et al.
The Laryngoscope|July 22, 2016
Predicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinomaRyan P Goepfert, Jan S Lewin, Martha P Barrow, et al.
Pageof 61